Obstructive Sleep Apnea (OSA) Treated With a Potassium Channel Inhibitor (Q61907466)

From Wikidata
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
Obstructive Sleep Apnea (OSA) Treated With a Potassium Channel Inhibitor
clinical trial

    Statements

    SANDMAN (English)
    0 references
    Randomized, Multi-center, Double-blind, Placebo-controlled, Group-comparison Study to Investigate Safety, Tolerability and Pharmacodynamics of BAY2253651 After Administration of a Single Nasal Dose in 60 Subjects With Obstructive Sleep Apnea and Open Exploratory Evaluation of Safety and Local Tolerability of Repeated Doses in Patients (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    13 August 2018
    0 references
    31 January 2020
    0 references
    60
    0 references
    18 year
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit